Bacterial Infections  >>  Bexsero (meningococcal group B vaccine)  >>  Phase 3
Welcome,         Profile    Billing    Logout  

1 Trials

Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Bexsero (meningococcal group B vaccine) / GSK
NCT02106390 / 2016-005117-44: Safety and Immunogenicity of GlaxoSmithKline Biologicals Meningococcal Group B Vaccine When Administered Concomitantly With GlaxoSmithKline Biologicals MenACWY Conjugate Vaccine to Healthy Infants

Completed
3b
750
RoW
Meningococcal group B Vaccine, rMenB+OMV NZ, Bexsero®, Meningococcal ACWY Conjugate Vaccine, MenACWY, Menveo®
GlaxoSmithKline
Infections, Meningococcal
10/16
10/16

Download Options